The present invention relates to pharmaceutical compositions characterized in that they comprise a triphasic release system, which may be delayed release and/or extended release and/or modified release and/or immediate release, of at least three layers for the formation of at least one dosage unit, wherein each layer comprises, as active pharmaceutical ingredients, at least one corticosteroid agent of the betamethasone type and/or the pharmaceutically acceptable salts thereof, at least one non-steroidal antiinflammatory agent of the Aceclofenac type and/or the pharmaceutically acceptable salts thereof, and at least one pharmaceutically acceptable excipient. Also described is the novel production process. Said triphasic release system generates an enhanced treatment effect to combat inflammation and body pain.
